Literature DB >> 11819648

Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

Qi Niu, Zhao-You Tang, Zeng-Chen Ma, Lun-Xiu Qin, Lian-Hai Zhang.   

Abstract

Entities:  

Year:  2000        PMID： 11819648      PMCID： PMC4723558          DOI： 10.3748/wjg.v6.i4.565

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  28 in total

1.  Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice.

Authors:  Hui-Chuan Sun; Xiao-Ming Li; Qiong Xue; Jun Chen; Dong-Mei Gao; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

2.  Signaling vascular morphogenesis and maintenance.

Authors:  D Hanahan
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

Review 3.  Vascular endothelial growth factor and ocular neovascularization.

Authors:  J W Miller
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.

Authors:  A M Stapleton; P Zbell; M W Kattan; G Yang; T M Wheeler; P T Scardino; T C Thompson
Journal:  Cancer       Date:  1998-01-01       Impact factor: 6.860

5.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma.

Authors:  K Maeda; Y S Chung; Y Ogawa; S Takatsuka; S M Kang; M Ogawa; T Sawada; M Sowa
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

7.  Angiogenic protein expression in advanced epithelial ovarian cancer.

Authors:  D P Barton; A Cai; K Wendt; M Young; A Gamero; S De Cesare
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

8.  Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.

Authors:  B H Bochner; D Esrig; S Groshen; M Dickinson; N Weidner; P W Nichols; D G Skinner; R J Cote
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

9.  Quantitative analysis of vascular endothelial growth factor in primary breast cancer.

Authors:  M Toi; S Kondo; H Suzuki; Y Yamamoto; K Inada; T Imazawa; T Taniguchi; T Tominaga
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

10.  Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.

Authors:  S Yamamoto; I Konishi; M Mandai; H Kuroda; T Komatsu; K Nanbu; H Sakahara; T Mori
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
View more
  17 in total

1.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.

Authors:  Wen-Jiao Zeng; Guo-Yuan Liu; Jie Xu; Xin-Da Zhou; Yue-E Zhang; Nong Zhang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation.

Authors:  Kun-Ching Lee; Wei-Ting Chen; Yu-Chang Liu; Song-Shei Lin; Fei-Ting Hsu
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

4.  DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Authors:  Zhao-Chong Zeng; Guo-Liang Jiang; Guo-Min Wang; Zhao-You Tang; Walter J Curran; George Iliakis
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.

Authors:  Lian-Jun Yang; Wen-Liang Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 6.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 7.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

8.  Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.

Authors:  Jie Cao; Shimin Luo; Lijian Liang; Jiaming Lai; Shanming Chen
Journal:  Front Med China       Date:  2007-07-01

9.  Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.

Authors:  Shi-Min Luo; Li-Jian Liang; Jia-Ming Lai
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 10.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.